Molecular targeting of E3 ligases – a therapeutic approac

**Curis helping to treat cancer, neurological degenerative, kidney disorders, CUDC-101. Pathways, hedgehog, EGFR, Her2, Hsp90, Bcr-Abl/Src, CDK, BCL, MEK, VEGF, HDAC.**

Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Expert Opinion's
Reply to topic
Molecular targeting of E3 ligases – a therapeutic approac
RSS FEED


Joined: 05 Apr 2006
Posts: 19275
Post Posted: Mon Jun 23, 2008 1:32 pm Reply with quote


Expert Opinion on Therapeutic Targets , July 2008, Vol. 12, No. 7, Pages 855-870.
<br/>
Background: The ubiquitin-proteasomal degradation pathway plays a critical role in protein degradation and regulates a wide variety of cellular functions. This highly conserved post-translational modification of proteolytic processes is mainly carried out ...

Read more...

Source: Expert Opinion: Expert Opinion on Therapeutic Targets: Table of Contents
Table of Contents for Expert Opinion on Therapeutic Targets. List of articles from both the latest and ahead of print issues.
View user's profileSend private message
Molecular targeting of E3 ligases – a therapeutic approac
All times are GMT - 7 Hours  
Page 1 of 1  
  
  
Pathway 2 Curis Forum (Hedgehog and beyond) Forum Index » Expert Opinion's
 Reply to topic  
Forum Map
Site Map